BullFrog AI shares are trading higher after the company announced US patent for novel prodrugs of mebendazole and their use in treating cancer.
Portfolio Pulse from Benzinga Newsdesk
BullFrog AI has announced a US patent for novel prodrugs of mebendazole, which are used in treating cancer. This news has led to an increase in the company's share price.
July 25, 2023 | 11:59 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
BullFrog AI's shares are trading higher after the company announced a US patent for novel prodrugs of mebendazole used in cancer treatment.
The announcement of a new patent for a product used in cancer treatment is significant news for BullFrog AI. This development not only strengthens the company's product portfolio but also potentially opens up new revenue streams. As a result, investors are reacting positively, leading to an increase in the company's share price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100